Ovid Therapeutics Inc. Active Patents
46 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-10-25: Application 18494155; Invention METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS; Applicant Ovid Therapeutics Inc.; Status Patented Case.
- 2023-05-30: Application 18325548; Invention METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS; Applicant Ovid Therapeutics Inc.; Status Patented Case.
- 2023-04-19: Application 18302997; Invention USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS, (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND VIGABATRIN IN THE TREATMENT OF DEVELOPMENTAL DISORDERS; Applicant Ovid Therapeutics Inc.; Status Patented Case.
- 2023-04-06: Application 18296532; Invention METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS; Applicant Ovid Therapeutics Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-25 | 18494155 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS | Ovid Therapeutics Inc. | Patented Case | 2024-03-05 | 11918563 | US20240066011A1 | Matthew DURING | United States | SHIAO, REI TSANG |
| 2023-05-30 | 18325548 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS | Ovid Therapeutics Inc. | Patented Case | 2024-02-20 | 11903930 | US20230293502A1 | Matthew During | United States | SHIAO, REI TSANG |
| 2023-04-19 | 18302997 | USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS, (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND VIGABATRIN IN THE TREATMENT OF DEVELOPMENTAL DISORDERS | Ovid Therapeutics Inc. | Patented Case | 2025-04-29 | 12285397 | US20230255914A1 | Matthew During Brett Abrahams | United States United States | CHONG, YONG SOO |
| 2023-04-06 | 18296532 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS | Ovid Therapeutics Inc. | Patented Case | 2023-11-07 | 11806336 | US20230293501A1 | Matthew During | United States | SHIAO, REI TSANG |
| 2022-11-04 | 17981148 | METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL | Ovid Therapeutics Inc. | Patented Case | 2025-11-11 | 12465597 | US20230071127A1 | Matthew DURING | United States | KOSTURKO, GEORGE W |
| 2022-07-13 | 17863902 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS | Ovid Therapeutics Inc. | Patented Case | 2024-11-19 | 12144801 | US20220362224A1 | Matthew During | United States | SHIAO, REI TSANG |
| 2022-06-17 | 17843028 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS | Ovid Therapeutics, Inc. | Patented Case | 2024-10-08 | 12109201 | US20220323424A1 | Matthew During | United States | SHIAO, REI TSANG |
| 2021-05-17 | 17322853 | METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME | Ovid Therapeutics Inc. | Patented Case | 2024-03-05 | 11918551 | US20230149332A1 | Matthew DURING | United States | KOSTURKO, GEORGE W |
| 2020-12-18 | 17126168 | GABOXADOL FOR THERAPEUTIC TREATMENT OF 1p36 DELETION SYNDROME | Ovid Therapeutics Inc. | Patented Case | 2022-06-21 | 11364228 | US20210186938A1 | Matthew DURING | United States | AULAKH, CHARANJIT |
| 2020-11-17 | 16950395 | USE OF MIR101 OR MIR128 IN THE TREATMENT OF SEIZURE DISORDERS | Ovid Therapeutics Inc. | Patented Case | 2023-09-19 | 11761006 | US20210095292A1 | Matthew DURING | United States | GIBBS, TERRA C |
| 2020-10-16 | 17072511 | USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS, (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND VIGABATRIN IN THE TREATMENT OF DEVELOPMENTAL DISORDERS | Ovid Therapeutics Inc. | Patented Case | 2023-05-30 | 11660277 | US20210100763A1 | Matthew DURING Brett ABRAHAMS | United States United States | CHONG, YONG SOO |
| 2020-08-20 | 16998295 | USE OF GABOXADOL FOR THE TREATMENT OF TOURETTE SYNDROME, TICS AND STUTTERING | Ovid Therapeutics Inc. | Patented Case | 2021-08-17 | 11090293 | US20200375960A1 | Matthew DURING | United States | AULAKH, CHARANJIT |
| 2020-07-07 | 16922273 | USE OF MIR-92A OR MIR-145 IN THE TREATMENT OF ANGELMAN SYNDROME | Ovid Therapeutics Inc. | Patented Case | 2021-09-28 | 11130952 | US20200332294A1 | Matthew DURING | United States | HUDSON, AMY ROSE |
| 2020-04-17 | 16851268 | USE OF (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF TINNITUS, ACUTE SENSORINEURAL HEARING LOSS, MENIERE'S DISEASE, TOURETTE'S SYNDROME, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ADDICTION | Ovid Therapeutics Inc. | Patented Case | 2023-10-03 | 11771671 | US20200246293A1 | Matthew DURING | United States | BARSKY, JARED |
| 2020-02-13 | 16789709 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS | Ovid Therapeutics Inc. | Patented Case | 2020-10-13 | 10799485 | US20200179350A1 | Matthew DURING | United States | SHIAO, REI TSANG |
| 2019-12-17 | 16717203 | USE OF GABOXADOL FOR THE TREATMENT OF NON-24 HOUR SLEEP-WAKE DISORDER | Ovid Therapeutics Inc. | Patented Case | 2023-07-04 | 11690829 | US20200188365A1 | Matthew DURING | United States | ANDERSON, JAMES D |
| 2019-09-20 | 16577084 | USE OF GABOXADOL FOR THE TREATMENT OF TOURETTE SYNDROME, TICS AND STUTTERING | Ovid Therapeutics Inc. | Patented Case | 2020-09-08 | 10765666 | US20200093806A1 | Matthew DURING | United States | AULAKH, CHARANJIT |
| 2019-08-13 | 16539081 | METHODS OF TREATING DEVELOPMENTAL DISORDERS AND/ | Ovid Therapeutics Inc. | Patented Case | 2021-02-23 | 10925879 | US20200000813A1 | Matthew DURING | United States | HOWELL, THEODORE R |
| 2019-06-20 | 16447300 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS | Ovid Therapeutics Inc. | Patented Case | 2020-03-31 | 10603308 | US20190307733A1 | Matthew DURING | United States | SHIAO, REI TSANG |
| 2019-06-14 | 16441391 | USE OF MIR-92A OR MIR-145 IN THE TREATMENT OF ANGELMAN SYNDROME | Ovid Therapeutics Inc. | Patented Case | 2020-07-07 | 10704048 | US20190382761A1 | Matthew DURING | United States | HUDSON, AMY ROSE |
| 2019-06-07 | 16434300 | USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS, (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND VIGABATRIN IN THE TREATMENT OF DEVELOPMENTAL DISORDERS | Ovid Therapeutics Inc. | Patented Case | 2020-10-27 | 10813899 | US20190374492A1 | Matthew DURING Brett ABRAHAMS | United States United States | CHONG, YONG SOO |
| 2019-03-18 | 16356517 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS | Ovid Therapeutics Inc. | Patented Case | 2019-07-30 | 10363246 | US20190216785A1 | Matthew DURING | United States | SCHMITT, MICHAEL J |
| 2019-02-15 | 16277037 | METHODS OF TREATING DEVELOPMENTAL SYNDROMES WITH PDE10A INHIBITORS | Ovid Therapeutics Inc. | Patented Case | 2020-08-11 | 10736894 | US20190247394A1 | Matthew DURING | United States | HENLEY III, RAYMOND J |
| 2019-02-08 | 16270856 | USE OF (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF TINNITUS, ACUTE SENSORINEURAL HEARING LOSS, MENIERE'S DISEASE, TOURETTE'S SYNDROME, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ADDICTION | Ovid Therapeutics Inc. | Patented Case | 2020-05-19 | 10653652 | US20190240174A1 | Matthew DURING | United States | BARSKY, JARED |
| 2018-12-17 | 16221794 | METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL | Ovid Therapeutics Inc. | Patented Case | 2021-08-24 | 11096929 | US20190117632A1 | Matthew DURING | United States | KOSTURKO, GEORGE W |
| 2018-12-06 | 16211309 | USE OF MIR101 OR MIR128 IN THE TREATMENT OF SEIZURE DISORDERS | Ovid Therapeutics Inc. | Patented Case | 2020-12-22 | 10870855 | US20190169619A1 | Matthew DURING | United States | GIBBS, TERRA C |
| 2018-11-08 | 16183933 | METHODS OF TREATING BEHAVIORAL SYNDROMES USING PIPRADROL | Ovid Therapeutics Inc. | Patented Case | 2019-12-03 | 10493069 | US20190076415A1 | Matthew DURING | United States | IVANOVA, SVETLANA M |
| 2018-10-11 | 16157653 | METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH BIGUANIDES | Ovid Therapeutics Inc. | Patented Case | 2019-10-01 | 10426746 | US20190046480A1 | Matthew DURING | United States | HUI, SAN MING R |
| 2018-08-07 | 16056754 | USE OF GABOXADOL IN THE TREATMENT OF TINNITUS | Ovid Therapeutics Inc. | Patented Case | 2019-01-29 | 10188635 | US20180344709A1 | Matthew DURING | United States | HUI, SAN MING R |
| 2018-06-29 | 16023282 | METHODS FOR TREATING AGGRESSION ASSOCIATED WITH ALZHEIMERS DISEASE | Ovid Therapeutics Inc. | Patented Case | 2022-03-22 | 11278529 | US20180303805A1 | Matthew During | United States | POLANSKY, GREGG |
| 2018-04-24 | 15961002 | METHODS OF TREATING DEVELOPMENTAL DISORDERS AND/ | Ovid Therapeutics Inc. | Patented Case | 2019-09-24 | 10420773 | US20190091231A1 | Matthew DURING | United States | HOWELL, THEODORE R |
| 2018-04-12 | 15951580 | METHODS OF TREATING DEVELOPMENTAL ENCEPHALOPATHIES | Ovid Therapeutics Inc. | Patented Case | 2020-09-08 | 10765646 | US20180296501A1 | Matthew DURING | United States | HOWELL, THEODORE R |
| 2018-02-26 | 15904901 | METHODS OF TREATING SEIZURE DISORDERS | Ovid Therapeutics Inc. | Patented Case | 2019-04-23 | 10265300 | US20180243266A1 | Matthew DURING | United States | WEDDINGTON, KEVIN E |
| 2018-01-17 | 15873425 | USE OF GABOXADOL IN THE TREATMENT OF TINNITUS | Ovid Therapeutics Inc. | Patented Case | 2018-09-11 | 10071083 | US20180221355A1 | Matthew DURING | United States | HUI, SAN MING R |
| 2017-08-22 | 15682967 | METHODS OF TREATING PRADER-WILLI SYNDROME | Ovid Therapeutics Inc. | Patented Case | 2019-02-05 | 10195165 | US20170348255A1 | Matthew DURING | United States | RAO, SAVITHA M |
| 2017-08-18 | 15680417 | METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH BIGUANIDES | Ovid Therapeutics Inc. | Patented Case | 2018-11-13 | 10123979 | US20180050001A1 | Matthew DURING | United States | HUI, SAN MING R |
| 2017-06-27 | 15634250 | METHODS OF SEDATION DURING CRITICAL CARE TREATMENT | Ovid Therapeutics Inc. | Patented Case | 2018-10-30 | 10111865 | US20170296519A1 | Matthew DURING Anna KAZANCHYAN | United States United States | SOLOLA, TAOFIQ A |
| 2017-05-25 | 15604776 | METHODS OF TREATING BEHAVIORAL SYNDROMES USING PIPRADROL | Ovid Therapeutics Inc. | Patented Case | 2017-11-28 | 9827233 | US20170340619A1 | Matthew DURING | United States | IVANOVA, SVETLANA M |
| 2016-12-12 | 15375735 | METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA | Ovid Therapeutics Inc. | Patented Case | 2017-10-31 | 9801864 | US20170087133A1 | Matthew DURING | United States | VALENROD, YEVGENY |
| 2016-11-04 | 15343690 | METHODS OF TREATING RETT SYNDROME | Ovid Therapeutics Inc. | Patented Case | 2017-08-29 | 9744159 | US20170071917A1 | Matthew DURING | United States | WRIGHT, SONYA N |
| 2016-06-23 | 15191068 | METHODS OF TREATING DRAVET SYNDROME | Ovid Therapeutics Inc. | Patented Case | 2017-06-20 | 9682069 | US20170014392A1 | Matthew DURING | United States | SZNAIDMAN, MARCOS L |
| 2016-06-17 | 15185650 | METHODS OF SEDATION DURING CRITICAL CARE TREATMENT | Ovid Therapeutics Inc. | Patented Case | 2017-08-01 | 9717716 | US20170042863A1 | Matthew DURING Anna KAZANCHYAN | United States United States | SOLOLA, TAOFIQ A |
| 2016-05-16 | 15155625 | METHODS OF TREATING PRADER-WILLI SYNDROME | Ovid Therapeutics Inc. | Patented Case | 2017-04-04 | 9610261 | US20160346232A1 | Matthew DURING | United States | RAO, SAVITHA M |
| 2016-04-19 | 15132641 | METHODS OF INCREASING TONIC INHIBITION AND TREATING FRAGILE X SYNDROME AND ANGELMAN SYNDROME | Ovid Therapeutics Inc. | Patented Case | 2016-09-20 | 9446028 | US20160228418A1 | Matthew DURING | United States | VALENROD, YEVGENY |
| 2015-10-19 | 14886764 | METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA | Ovid Therapeutics Inc. | Patented Case | 2016-05-17 | 9339495 | US20160038469A1 | Matthew DURING | United States | VALENROD, YEVGENY |
| 2015-08-24 | 14834027 | METHODS OF SEDATION DURING CRITICAL CARE TREATMENT | Ovid Therapeutics Inc. | Patented Case | 2016-07-26 | 9399034 | Matthew DURING Anna Kazanchyan | United States United States | SOLOLA, TAOFIQ A |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |